Some advocates of alternative medicine simply swear by remedies, while others will show you the science behind why it works. Here, we’ll show you the studies and explain the science.
Health News from ScienceDaily
- Vaccine misinformation and social media on February 17, 2020 at 9:30 pm
People who rely on social media for information were more likely to be misinformed about vaccines than those who rely on traditional media, according to a new study. The study, based on surveys of nearly 2,500 US adults, found that up to 20% of respondents were at least somewhat misinformed about vaccines.
- New guidelines on aspirin in primary prevention on February 17, 2020 at 9:23 pm
New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at higher risks of cardiovascular events than those under 70. As a result, health care providers are understandably confused about whether or not to prescribe aspirin for primary prevention of heart attacks or strokes, and if so, to whom.
- States with highest rates of melanoma due to ultraviolet radiation identified on February 17, 2020 at 1:52 pm
A new study finds a wide state-by-state variation in rates of melanoma caused by ultraviolet (UV) exposure with highest rates in several states on the East and West Coast including Hawaii, but also a few landlocked states, including Utah, Vermont, and Minnesota.
- The skinny on why poor sleep may increase heart risk in women on February 17, 2020 at 1:52 pm
A new study suggests that for women, poor sleep could contribute to unhealthy food choices, increasing the risk of obesity and heart disease.
- Combination drug therapy for childhood brain tumors shows promise in laboratory models on February 17, 2020 at 1:52 pm
In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.